Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

OOrganon & Co.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
O

Organon & Co.

  • Overview
  • Financial statements
  • Metrics
    • Revenue & profit
    • Revenue by segment
    • Launches
    • Revenue concentration
    • Margins
    • Contracted revenue
    • Off-balance-sheet commitments
    • Cash flow
    • Cash & debt
    • Earnings per share
    • P/E ratio
    • Share count & dilution
  • Quarterly earnings
  • Similar companies
  • History
  • Insider Transactions
Loading financial graphs

Metrics

Revenue & profit
Revenue by segment
Margins
Contracted revenue
Cash flow
Cash & debt
Earnings per share
Share count & dilution

Metrics

Compare sales with the profit left after direct costs and the profit left after all expenses and taxes.Formula: Gross profit = revenue − cost of revenue Net income = total income − total expenses
Q2 ’2620192020202120222023202420250500M1B1.5BLatest period Q2 '26. Revenue 1.56B. Gross profit 847M. Net profit 108M.
RevenueGross profitNet profit
See which business lines, products, or regions generate the company’s sales.Formula: Company revenue = Σ(segment revenues) + reconciliation adjustments
Q2 ’2620192020202120222023202420250500M1B1.5BLatest period Q2 '26. Arcoxia 69M. Atozet 80M. Brenzys 14M. Clarinex 30M. Cozaar Hyzaar 50M. Diprospan 44M. Dulera 41M. Follistim AQ 59M. Fosamax 25M. Nasonex 58M. Nexplanon Implanon NXT 230M. Nuva Ring 27M. Ontruzant 6M. Other Biosimilars 12M. Other Cardiovascular 25M. Other Non Opiod Pain Bone And Dermatology 79M. Other Respiratory 18M. Other Sundry Established Brands 96M. Other Sundry Products 14M. Other Womens Health 45M. Propecia 36M. Proscar 20M. Renflexis 65M. Rosuzet 5M. Singulair 48M. Vytorin 21M. Zetia 96M. Hadlima 79M. Marvelon Mercilon 32M. Ganirelix Acetate Injection 26M. Jada 0. Emgality Ravvow 54M. Vtama 35M. Bildvos Bilprevda 19M.
ArcoxiaAsmanexAtozetBrenzysCerazetteClarinexCozaar HyzaarDiprosoneDiprospanDuleraFollistim AQFosamaxNasonexNexplanon Implanon NXTNuva RingOntruzantOrgalutronOther BiosimilarsOther CardiovascularOther Non Opiod Pain Bone And DermatologyOther RespiratoryOther Sundry Established BrandsOther Sundry ProductsOther Womens HealthPropeciaProscarRemeronRenflexisRosuzetSinemetSingulairVytorinZetiaZocorAybintioHadlimaMarvelon MercilonGanirelix Acetate InjectionJadaEmgality RavvowVtamaTofidenceBildvos Bilprevda
See how much of each dollar of sales remains after direct costs, after running the business, and after all expenses and taxes.Formula: Gross margin = gross profit ÷ revenue × 100% Operating margin = operating income ÷ revenue × 100% Net margin = net income ÷ revenue × 100%
Q2 ’2620192020202120222023202420250%20%40%60%Latest period Q2 '26. Gross margin 54.4%. Net profit margin 6.9%.
Gross marginOperating marginNet profit margin
See the amounts the company has committed to pay that its balance sheet does not record yet: leases it has signed that have not started, unconditional purchase and other contractual commitments, and the most it could have to pay under guarantees and credit backstops. Amounts are as the filing reports them at each balance-sheet date.Formula: Commitments = leases not yet commenced + purchase & other commitments + maximum guarantee exposure
Q4 ’2520192020202120222023202420250500M1B1.5B
      Latest period Q4 '25. Purchase & other commitments 947M.
      Leases not yet commencedPurchase & other commitmentsGuarantees & contingent commitments
      Compare cash generated by the business, spending on long-lived assets, and what remains afterward.Formula: Free cash flow = operating cash flow − capital expenditures
      $
      Q2 ’2620192020202120222023202420250500M1B
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        • Capex: purchases of property, plant and equipment
        Latest period Q2 '26. Operating cash flow 107M. Capex -42M. Free cash flow 65M.
        Operating cash flowCapexFree cash flow
        Compare the company’s cash cushion with its borrowings. Negative net cash means debt is greater than cash.Formula: Net cash = cash − debt
        2026201920202021202220232024202502B4B6B8B
            Latest period 2026. Cash 1.1B. Debt 8.6B.
            CashDebtNet cash
            Profit for each share over the trailing 12 months, adjusted for stock splits.Formula: Earnings available to common shareholders ÷ weighted-average shares
            $/shareUsing split history cached 2026-09-23; assuming no new splits
            four_consecutive_quarters_unavailableMissingfour_consecutive_quarters_unavailableMissingfour_consecutive_quarters_unavailableMissingQ2 ’2620192020202120222023202420250.005.0010.00
            • Q1 2020: four consecutive quarters unavailable
            • Q2 2020: four consecutive quarters unavailable
            • Q3 2020: four consecutive quarters unavailable
            • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2022-03-14: 253,637,179 source shares. Uses later-dated shares from the same quarterly filing.
            • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: unavailable source shares.
            • Earnings period 2020-04-01 to 2020-06-30. Shares as of 2020-06-30: unavailable source shares.
            • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-09-30: unavailable source shares.
            • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2023-02-22: 254,382,732 source shares. Uses later-dated shares from the same quarterly filing.
            • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-06-15: 253,516,000 source shares. Uses later-dated shares from the same quarterly filing.
            • Earnings period 2021-04-01 to 2021-06-30. Shares as of 2021-06-30: 253,516,000 source shares.
            • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-09-30: 253,545,051 source shares.
            • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 253,550,000 source shares.
            • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 253,637,179 source shares.
            • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-06-30: 254,321,000 source shares.
            • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 254,364,000 source shares.
            • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 254,370,000 source shares.
            • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 254,432,000 source shares.
            • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 255,568,000 source shares.
            • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 255,606,000 source shares.
            • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 255,626,000 source shares.
            • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 255,847,000 source shares.
            • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 257,473,000 source shares.
            • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 257,539,000 source shares.
            • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 257,799,000 source shares.
            • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 257,950,000 source shares.
            • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 259,965,000 source shares.
            • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 259,983,000 source shares.
            • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 260,316,000 source shares.
            • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 262,649,000 source shares.
            • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 262,609,000 source shares.
            Latest period Q2 2026. EPS (TTM) 0.80.
            EPS (TTM)
            How much investors pay for each dollar of the company’s yearly earnings. It is not useful when the company has no profit.Formula: Share price ÷ trailing 12-month EPS
            Using split history cached 2026-09-23; assuming no new splits
            Security type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingSecurity type not verifiedMissingQ2 ’2620192020202120222023202420250x0.2x0.4x0.6x0.8x1x
            • FY 2019: Security type not verified
            • Q1 2020: Security type not verified
            • Q2 2020: Security type not verified
            • Q3 2020: Security type not verified
            • FY 2020: Security type not verified
            • Q1 2021: Security type not verified
            • Q2 2021: Security type not verified
            • Q3 2021: Security type not verified
            • FY 2021: Security type not verified
            • Q1 2022: Security type not verified
            • Q2 2022: Security type not verified
            • Q3 2022: Security type not verified
            • FY 2022: Security type not verified
            • Q1 2023: Security type not verified
            • Q2 2023: Security type not verified
            • Q3 2023: Security type not verified
            • FY 2023: Security type not verified
            • Q1 2024: Security type not verified
            • Q2 2024: Security type not verified
            • Q3 2024: Security type not verified
            • FY 2024: Security type not verified
            • Q1 2025: Security type not verified
            • Q2 2025: Security type not verified
            • Q3 2025: Security type not verified
            • FY 2025: Security type not verified
            • Q1 2026: Security type not verified
            • Q2 2026: Security type not verified
            • Earnings period 2019-01-01 to 2019-12-31. Shares as of 2022-03-14: 253,637,179 source shares. Uses later-dated shares from the same quarterly filing.
            • Earnings period 2020-01-01 to 2020-03-31. Shares as of 2020-03-31: unavailable source shares.
            • Earnings period 2020-04-01 to 2020-06-30. Shares as of 2020-06-30: unavailable source shares.
            • Earnings period 2020-07-01 to 2020-09-30. Shares as of 2020-09-30: unavailable source shares.
            • Earnings period 2020-01-01 to 2020-12-31. Shares as of 2023-02-22: 254,382,732 source shares. Uses later-dated shares from the same quarterly filing.
            • Earnings period 2021-01-01 to 2021-03-31. Shares as of 2021-06-15: 253,516,000 source shares. Uses later-dated shares from the same quarterly filing.
            • Earnings period 2021-04-01 to 2021-06-30. Shares as of 2021-06-30: 253,516,000 source shares.
            • Earnings period 2021-07-01 to 2021-09-30. Shares as of 2021-09-30: 253,545,051 source shares.
            • Earnings period 2021-01-01 to 2021-12-31. Shares as of 2021-12-31: 253,550,000 source shares.
            • Earnings period 2022-01-01 to 2022-03-31. Shares as of 2022-03-31: 253,637,179 source shares.
            • Earnings period 2022-04-01 to 2022-06-30. Shares as of 2022-06-30: 254,321,000 source shares.
            • Earnings period 2022-07-01 to 2022-09-30. Shares as of 2022-09-30: 254,364,000 source shares.
            • Earnings period 2022-01-01 to 2022-12-31. Shares as of 2022-12-31: 254,370,000 source shares.
            • Earnings period 2023-01-01 to 2023-03-31. Shares as of 2023-03-31: 254,432,000 source shares.
            • Earnings period 2023-04-01 to 2023-06-30. Shares as of 2023-06-30: 255,568,000 source shares.
            • Earnings period 2023-07-01 to 2023-09-30. Shares as of 2023-09-30: 255,606,000 source shares.
            • Earnings period 2023-01-01 to 2023-12-31. Shares as of 2023-12-31: 255,626,000 source shares.
            • Earnings period 2024-01-01 to 2024-03-31. Shares as of 2024-03-31: 255,847,000 source shares.
            • Earnings period 2024-04-01 to 2024-06-30. Shares as of 2024-06-30: 257,473,000 source shares.
            • Earnings period 2024-07-01 to 2024-09-30. Shares as of 2024-09-30: 257,539,000 source shares.
            • Earnings period 2024-01-01 to 2024-12-31. Shares as of 2024-12-31: 257,799,000 source shares.
            • Earnings period 2025-01-01 to 2025-03-31. Shares as of 2025-03-31: 257,950,000 source shares.
            • Earnings period 2025-04-01 to 2025-06-30. Shares as of 2025-06-30: 259,965,000 source shares.
            • Earnings period 2025-07-01 to 2025-09-30. Shares as of 2025-09-30: 259,983,000 source shares.
            • Earnings period 2025-01-01 to 2025-12-31. Shares as of 2025-12-31: 260,316,000 source shares.
            • Earnings period 2026-01-01 to 2026-03-31. Shares as of 2026-03-31: 262,649,000 source shares.
            • Earnings period 2026-04-01 to 2026-06-30. Shares as of 2026-06-30: 262,609,000 source shares.
            Latest period Q2 2026. P/E ratio Missing.
            P/E ratio
            See how the number of shares changes over time. More shares can mean each existing share owns a smaller slice of the company.Formula: Outstanding shares = issued shares − treasury shares Share-count growth = (current shares ÷ previous shares − 1) × 100%
            Stock split history may be out of date.
            20262019202020212022202320242025050M100M150M200M250M
                Latest period 2026. Shares outstanding 262.6M. Class detail unavailable 262.6M.
                Class detail unavailable